indobufen has been researched along with Pleurisy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerletti, C; Colombo, M; Manarini, S; Tavani, A | 1 |
1 other study(ies) available for indobufen and Pleurisy
| Article | Year |
|---|---|
The (+)-enantiomer is responsible for the antiplatelet and anti-inflammatory activity of (+/-)-indobufen.
Topics: Animals; Gastric Mucosa; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pleurisy; Rats; Rats, Inbred Strains; Stereoisomerism; Thromboxane B2 | 1990 |